* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results on October
26.
* The South Jordan Utah-based company is expected to report
a
2.0% increase in revenue to $272.359 million from $267.02
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. The company's guidance on
July 27 2022, for the period ended September 30, was for revenue
between $269.69 million and $277.70 million.
* Refinitiv's mean analyst estimate for Merit Medical
Systems Inc
is for earnings of 53 cents per share. The company's EPS
guidance on July 27 2022, for the period ended September 30, was
between USD0.494 and USD0.546
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $72, above its last closing price of $58.00.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.58 0.58 0.73 Beat 26.3
Mar. 31 2022 0.47 0.47 0.53 Beat 13.9
Dec. 31 2021 0.51 0.52 0.71 Beat 36.5
Sep. 30 2021 0.44 0.44 0.52 Beat 19.2
Jun. 0.45 0.44 0.62 Beat 39.7
30 2021
Mar. 31 2021 0.36 0.36 0.52 Beat 45.4
Dec. 31 2020 0.44 0.43 0.54 Beat 24.3
Sep. 30 2020 0.19 0.20 0.42 Beat 112.4
This summary was machine generated October 25 at 00:02 GMT. All
figures in US dollars unless otherwise stated